| Literature DB >> 30140327 |
L Starczewska-Dymek1, A Bozek2, M Jakalski2.
Abstract
The forced oscillation technique (FOT) requires minimal patient cooperation and is useful for children. However, comprehensive values of respiratory impedance at baseline and after the reversibility test have not been definitively confirmed. The aim of this study was to evaluate the basic parameters of FOT reactance (Xrs) and resistance (Rrs) in groups of healthy children and children with controlled and uncontrolled asthma. The second aim was the assessment of the reversibility bronchial test using the forced oscillation method in children with bronchial asthma. Materials and Methods. One hundred and six children aged from 2 to 6 years diagnosed with early-onset controlled or uncontrolled asthma and healthy controls were included in this single-center, prospective, randomized study. All asthmatic patients and healthy controls underwent basic FOT as one measurement according to the recommendation of Resmon Pro FOT. The reversibility test was then performed 15 min after the administration of 200 mcg salbutamol by MDI in all patients. Results. Basic Rrs showed significantly higher mean values in patients with uncontrolled asthma compared to patients with controlled asthma, which were in turn higher than the values for patients in the control group (11.14 ± 1.29 versus 15.71 ± 2.6 versus 9.21 ± 0.98, resp.; p < 0.05). The data analysis showed similar relationships in terms of the Xrs between the studied groups (-4.76 ± 1.19 versus -7.31 ± 2.33 versus -2.11 ± 0.48, resp.; p < 0.05). According to the changes in the Rrs values, 35 (66%) positive bronchial reversibility tests were obtained in 53 subjects with controlled asthma and in 39 (74%) subjects with uncontrolled asthma. Conclusions. Rrs and Xrs obtained by FOT well-discriminate patients with asthma from healthy children. A bronchial reversibility test involving the use of FOT is valuable for the diagnosis of bronchial asthma.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30140327 PMCID: PMC6081498 DOI: 10.1155/2018/7519592
Source DB: PubMed Journal: Can Respir J ISSN: 1198-2241 Impact factor: 2.409
Characteristics of the studied groups.
| Feature | AK ( | ANK ( | K ( |
|
|---|---|---|---|---|
| Age | 4.2 ± 1.3 | 4.8 ± 2.1 | 3.9 ± 1.2 | NS |
| Women (%) | 52.6 | 48.9 | 56.1 | NS |
| Height (cm) | 105.8 ± 8.9 | 110.1 ± 10.2 | 102.8 ± 12.1 | NS |
| BMI | 15.21 | 13.96 | 16.21 | NS |
| Atopy (%) | 26 (49.1) | 27 (50.9) | 24 (46.6) | NS |
| Time from the diagnosis of asthma in months (%) | 19.5 ± 2.8 | 17.4 ± 4.2 | — | NS |
| Atopy in family (%) | 36 (67.9) | 35 (66) | 29 (64.4) | NS |
| AR (%) | 25 (47.2) | 21 (39.6) | 20 (44.4) | NS |
| AD (%) | 24 (45.3) | 26 (49.1) | 21 (46.7) | NS |
| Food allergy (%) | 16 (30.2) | 11 (20.8) | 12 (26.7) | NS |
AK: patients with controlled asthma; ANK: patients with uncontrolled asthma; K: control group; AR: allergic rhinitis; AD: dermatitis allergica; Student's t-tests for related samples or the chi-square test were used.
Comparison of Rrs values in the studied groups.
| Rrs ( hPa·sL−1) | AK | ANK | K |
|---|---|---|---|
| Total | 11.14 | 15.71 | 9.21^ |
| (95% CI: 9.93–13.17) | (95% CI: 13.49–18.11) | (95% CI: 7.59–9.86) | |
|
| |||
| Inhaled | 10.2 | 13.82 | 8.21^ |
| (95% CI: 8.53–11.95) | (95% CI: 12.03–14.05) | (95% CI: 6.23–8.84) | |
|
| |||
| Exhaled | 13.21 | 16.81 | 9.89^ |
| (95% CI: 11.13–14.82) | (95% CI: 15.11–17.03) | (95% CI: 7.64–11.15) | |
|
| |||
| Δ Rrs | 0.68 | 0.87 | 0.36^ |
| (95% CI: 0.61–0.73) | (95% CI: 0.75–1.02) | (95% CI: 0.26–0.47) | |
AK: patients with controlled asthma; ANK: patients with uncontrolled asthma; K: control group; Δ Rrs: the difference between the inspiration and expiration component for the resistance; significant differences (ANOVA test) between the following: AK and K, p < 0.05; ANC and K, p < 0.05; ^AK and ANC, p < 0.05.
Comparison of Xrs values in the studied groups.
| Xrs (hPa sL−1) | AK | ANK | K |
|---|---|---|---|
| Total | −4.76 | −7.31 | −2.11^ |
| (95% CI: −5.21; −3.32) | (95% CI: −8.21; −5.54) | (95% CI: −3.09; −1.12) | |
|
| |||
| Inhaled | −4.34 | −6.71 | −1.84^ |
| (95% CI: −5.68; −3.12) | (95% CI: −7.1; −5.89) | (95% CI: −2.81; −0.82) | |
|
| |||
| Exhaled | −5.76 | −8.49 | −2.89^ |
| (95% CI: −7.02; −4.12) | (95% CI: −9.91; −7.52) | (95% CI: −3.81; −1.19) | |
|
| |||
| Δ Xrs | 0.42 | 0.46 | 0.39 |
| (95% CI: 0.36–0.51) | (95% CI: 0.41–0.62) | (95% CI: 0.29–0.47) | |
AK: patients with controlled asthma; ANK: patients with uncontrolled asthma; K: control group; Δ Xrs: the difference between the inspiration and expiration component of the reactance; significant differences (ANOVA test) between the following: AK and K, p < 0.05; ANC and K, p < 0.05; ^AK and ANC, p < 0.05.
Figure 1ROC curves corresponding to the sensitivity and specificity of possible cutoff points for Δ Rrs (diamonds) and Δ Xrs (squares) for discriminating children with asthma (control and uncontrol) and without it (a) and for discriminating children with controlled and uncontrolled asthma (b).
Figure 2Percentage of changes in the Rrs and Xrs after salbutamol in comparison to baseline in the studied groups. XrsSD: average reactance with standard deviation; RrsSD: average resistance with standard deviation; significant differences (ANOVA test) for p < 0.05; AK: patients with controlled asthma; ANK: patients with uncontrolled asthma; K: control group.
Figure 3ROC curves corresponding to the sensitivity and specificity of possible cutoff points for changes in Rrs (diamonds) and Xrs (squares) pre- and postsalbutamol for discriminating children with asthma (control and uncontrol) and without it.
Figure 4Xrs and Rrs in relation to height. AK: patients with controlled asthma; ANK: patients with uncontrolled asthma; K: control group.